Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease - A Randomized Controlled Trial
Inclusion Criteria:
- Age 18 to 70 years
- Fatty liver by proton-magnetic resonance spectroscopy, defined as hepatic
triglyceride content 5% or above
- Serum alanine aminotransferase (ALT) above 30 U/L in men and 19 U/L in women
- Informed written consent obtained
Exclusion Criteria:
- Positive hepatitis B surface antigen, anti-hepatitis C virus antibody, or
anti-nuclear antibody titer above 1/160
- Alcohol consumption above 30 g per week in men or 20 g per week in women
- Alanine aminotransferase (ALT) above 10 times the upper limit of normal
- Liver decompensation, as evidenced by bilirubin above 50 µmol/l, platelet count below
100 × 10e9/l, prothrombin time above 1.3 times the upper limit of normal, albumin
below 35 g/l, presence of ascites or varices
- Evidence of hepatocellular carcinoma
- Terminal illness or cancer, unless in complete remission for more than 5 years